secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2026-03-17T23:59:59+00:00
Accession:  0001493152-26-010383
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience Q2 revenue up 13% to $443K; net loss narrows; USDA cert for PURE Clean
--------------------------------------------------------------------------------

- Net product sales Q2 $443K (up 13% YoY); six-month sales $1.15M (up 22% YoY).
- Net loss Q2 $785K ($0.01/sh) vs $798K; six-month loss $1.249M vs $1.487M.
- Received USDA Biobased Product Certification for new product PURE Clean; expects launch in fiscal Q3.
- Partner Bonsai expanding online promotion; exploring biomedical space with Quip Labs; growth in transportation.
- In-plant dairy trials at Cal Poly; new marketing campaign targeting dairy farmers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315226010383/0001493152-26-010383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315226010383/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-010383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer